Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Third Military Medical University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1954-01-01

Employees: 1

Market Cap: -

Website: http://www.tmmu.edu.cn

Clinical Trials

Use of the TDT for Prevention of Anastomotic Leakage After Laparoscopic Anterior Resection for Rectal Cancer

Not Applicable

Completed

Conditions: Anastomotic Leakage
Rectal Neoplasms

Interventions: Procedure: with TDT
Procedure: without TDT

First Posted Date: 2016-02-19

Last Posted Date: 2021-05-07

Lead Sponsor: Third Military Medical University

Target Recruit Count: 560

Registration Number: NCT02686567

Locations: 🇨🇳
Daping hospital, Chongqing, Chongqing, China

A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes

Phase 4

Conditions: Type 2 Diabetes

Interventions: Drug: Placebo
Drug: Mosapride

First Posted Date: 2015-11-17

Last Posted Date: 2015-11-17

Lead Sponsor: Third Military Medical University

Target Recruit Count: 200

Registration Number: NCT02606617

Cranial Temperature Early Diagnose Hemorrhagic and Ischemic Stroke

Conditions: Ischemic Stroke
Hemorrhagic Stroke

First Posted Date: 2015-11-10

Last Posted Date: 2016-06-21

Lead Sponsor: Third Military Medical University

Target Recruit Count: 60

Registration Number: NCT02601183

Locations: 🇨🇳
the Southwest hospital, Chongqing, Chongqing, China

Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment

Phase 4

Conditions: GLP-1；Metformin；Telomere-telomerase System；Par-4

Interventions: Drug: Liraglutide
Drug: Metformin

First Posted Date: 2015-08-28

Last Posted Date: 2016-09-13

Lead Sponsor: Third Military Medical University

Target Recruit Count: 200

Registration Number: NCT02535299

Locations: 🇨🇳
Southwest Hospital of the Third Military Medical University, Chongqing, Chongqing, China

Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment

Phase 3

Conditions: Irritable Bowel Syndrome

Interventions: Drug: Starch Placebo
Drug: N-acetyl-D-glucosamine

First Posted Date: 2015-07-21

Last Posted Date: 2015-07-21

Lead Sponsor: Third Military Medical University

Target Recruit Count: 720

Registration Number: NCT02504060

Locations: 🇨🇳
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Transanal Total Mesorectal Excision Versus Laparoscopic TME for Rectal Cancer

Not Applicable

Completed

Conditions: Rectal Neoplasms

Interventions: Procedure: transanal hybrid-laparoscopic total mesentery excision
Procedure: conventional laparoscopic total mesentery excision

First Posted Date: 2014-09-30

Last Posted Date: 2023-11-27

Lead Sponsor: Third Military Medical University

Target Recruit Count: 70

Registration Number: NCT02252250

Locations: 🇨🇳
Daping hospital, Chongqing, Chongqing, China

Serum CTRP3 and RBP4 Levels in Obesity and Hypertension

Completed

Conditions: Obesity
Hypertension

First Posted Date: 2014-08-27

Last Posted Date: 2014-08-27

Lead Sponsor: Third Military Medical University

Target Recruit Count: 2000

Registration Number: NCT02226471

Lumbar Intervertebral Disc Herniation

Not Applicable

Conditions: Lumbar Disc Herniation

Interventions: Procedure: Discectomy
Device: Dynamic Stabilization
Device: Instrumentation and fusion

First Posted Date: 2014-04-10

Last Posted Date: 2014-04-10

Lead Sponsor: Third Military Medical University

Target Recruit Count: 195

Registration Number: NCT02110186

Locations: 🇨🇳
The Third Military Medical University/Southwest Hospital, Chongqing, China

Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer

Phase 2

Conditions: Small Cell Lung Carcinoma

Interventions: Drug: Irinotecan
Drug: Cisplatin

First Posted Date: 2013-11-06

Last Posted Date: 2016-04-01

Lead Sponsor: Third Military Medical University

Target Recruit Count: 110

Registration Number: NCT01977235

Locations: 🇨🇳
Chongqing Cancer Hospital, Chongqing, Chongqing, China
🇨🇳
Xinan Hospital, Third Military Medical University, Chongqing, Chongqing, China
🇨🇳
Xinqiao Hospital, Third Military Medical University, Chongqing, Chongqing, China

Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression

Phase 3

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Gossypol
Drug: Placebo

First Posted Date: 2013-11-06

Last Posted Date: 2013-11-06

Lead Sponsor: Third Military Medical University

Target Recruit Count: 204

Registration Number: NCT01977209

Locations: 🇨🇳
Daping Hospital, Third Military Medical University, Chongqing, Chongqing, China
🇨🇳
Chongqing Zhongshan Hospital, Chongqing, Chongqing, China
🇨🇳
Fuling Central Hospital, Chongqing, Chongqing, China

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy